Illumina, Inc. (ILMN) compared with its closest peers (A, WAT, MTD, ONTO, RVTY): P/E 51.5 vs industry 51.8. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Agilent Technologies, Inc. (A) | $44.17B | 31.2 |
| Waters Corporation (WAT) | $39.76B | 239.3 |
| Mettler-Toledo International Inc. (MTD) | $30.21B | 38.3 |
| Onto Innovation Inc. (ONTO) | $14.67B | 59.6 |
| Revvity, Inc. (RVTY) | $13.85B | 77.0 |
| Bio-Rad Laboratories, Inc. (BIO) | $10.15B | 10.9 |
| Avantor, Inc. (AVTR) | $9.73B | -14.7 |
| Bruker Corporation (BRKR) | $9.13B | -314.1 |
| 10x Genomics, Inc. (TXG) | $8.16B | -46.6 |
| Alamar Biosciences, Inc. (ALMR) | $2.40B | — |
| Stock P/E | 51.5 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
| vs Sector | 51.9% |
| vs Industry | -0.6% |
ILMN overview · ILMN earnings · ILMN financials · ILMN KPIs · ILMN investor relations · ILMN ownership · ILMN filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.